| mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |
| mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
0.0041 |
0.9 |
| mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
0.0078 |
0.9 |
| mRNA |
BRD-K34485477 |
CTRPv2 |
pan-cancer |
AAC |
-0.0073 |
0.9 |
| mRNA |
BRD-K86535717 |
CTRPv2 |
pan-cancer |
AAC |
-0.0068 |
0.9 |
| mRNA |
simvastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
| mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
0.003 |
0.9 |
| mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.0044 |
0.9 |
| mRNA |
FGIN-1-27 |
CTRPv2 |
pan-cancer |
AAC |
0.005 |
0.9 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
0.9 |